Christopher Davis - Davis Selected Advisers
Holding/activity history for Sinovac Biotech Ltd. (SVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2014 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2014 Q2 | 1,250,546 | 0.02 | Add 0.51% | <0.01 | $5.64 | $7,053,000 | SEC |
| 2014 Q1 | 1,244,206 | 0.03 | Add 5.57% | <0.01 | $7.20 | $8,958,000 | SEC |
| 2013 Q4 | 1,178,606 | 0.02 | Reduce 20.00% | <0.01 | $6.12 | $7,213,000 | SEC |
| 2013 Q3 | 1,473,343 | 0.02 | Reduce 43.92% | 0.01 | $5.98 | $8,811,000 | SEC |
| 2013 Q2 | 2,627,231 | 0.03 | Add 1.23% | <0.01 | $3.93 | $10,325,000 | SEC |
| 2012 Q2 | 2,595,324 | 0.01 | Reduce 3.53% | <0.01 | $2.11 | $5,476,000 | SEC |
| 2012 Q1 | 2,690,338 | 0.01 | Add 2.72% | <0.01 | $2.04 | $5,488,000 | SEC |
| 2011 Q4 | 2,619,198 | 0.01 | Add 3.49% | <0.01 | $2.20 | $5,762,000 | SEC |
| 2011 Q3 | 2,530,808 | 0.02 | Add 2.92% | <0.01 | $2.23 | $5,644,000 | SEC |
| 2011 Q2 | 2,459,090 | 0.02 | Add 50.69% | <0.01 | $3.20 | $7,869,000 | SEC |
| 2011 Q1 | 1,631,880 | 0.02 | Add 27.14% | <0.01 | $4.52 | $7,384,000 | SEC |
| 2010 Q4 | 1,283,570 | 0.12 | Buy | 0.12 | $45.10 | $57,889,000 | SEC |